Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RET-PTC1 rearrangement
i
Other names:
RET, Ret Proto-Oncogene, Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret, Cadherin-Related Family Member 16, Rearranged During Transfection, RET Receptor Tyrosine Kinase, Cadherin Family Member 12, Proto-Oncogene C-Ret, CDHF12, CDHR16, PTC, Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease), Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease 1, RET-ELE1, HSCR1, MEN2A, MEN2B, RET51, MTC1, PTC1, Patched Ho
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5979
;
5727
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
RET overexpression (3)
RET expression (1)
RET positive (1)
RET positive + PD-L1 overexpression (1)
RET overexpression (3)
RET expression (1)
RET positive (1)
RET positive + PD-L1 overexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
MK-2206
Sensitive: D – Preclinical
MK-2206
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
dasatinib + CI-1040
Sensitive: D – Preclinical
dasatinib + CI-1040
Sensitive
:
D
dasatinib + CI-1040
Sensitive: D – Preclinical
dasatinib + CI-1040
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
dasatinib
Sensitive: D – Preclinical
dasatinib
Sensitive
:
D
dasatinib
Sensitive: D – Preclinical
dasatinib
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
cabozantinib capsule
Sensitive: D – Preclinical
cabozantinib capsule
Sensitive
:
D
cabozantinib capsule
Sensitive: D – Preclinical
cabozantinib capsule
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040 + SU6656
Sensitive: D – Preclinical
CI-1040 + SU6656
Sensitive
:
D
CI-1040 + SU6656
Sensitive: D – Preclinical
CI-1040 + SU6656
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040 + PP2
Sensitive: D – Preclinical
CI-1040 + PP2
Sensitive
:
D
CI-1040 + PP2
Sensitive: D – Preclinical
CI-1040 + PP2
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
CI-1040
Sensitive: D – Preclinical
CI-1040
Sensitive
:
D
CI-1040
Sensitive: D – Preclinical
CI-1040
Sensitive
:
D
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
RET-PTC1 rearrangement
Thyroid Gland Papillary Carcinoma
AZD1480
Sensitive: D – Preclinical
AZD1480
Sensitive
:
D
AZD1480
Sensitive: D – Preclinical
AZD1480
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.